Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab. [electronic resource]
Producer: 20170825Description: 1680-1687 p. digitalISSN:- 1523-5866
- Angiogenesis Inhibitors -- therapeutic use
- Bevacizumab -- therapeutic use
- Biomarkers
- Brain Neoplasms -- diagnostic imaging
- Diffusion Magnetic Resonance Imaging -- methods
- Disease-Free Survival
- Female
- Glioblastoma -- diagnostic imaging
- Humans
- Image Interpretation, Computer-Assisted
- Magnetic Resonance Imaging -- methods
- Male
- Middle Aged
- Multimodal Imaging -- methods
- Proportional Hazards Models
- Survival Analysis
- Tumor Burden
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.